Cargando…
HNO Protects the Myocardium against Reperfusion Injury, Inhibiting the mPTP Opening via PKCε Activation
Donors of nitroxyl (HNO), the one electron-reduction product of nitric oxide (NO(.)), positively modulate cardiac contractility/relaxation while limiting ischemia-reperfusion (I/R) injury. The mechanisms underpinning HNO anti-ischemic effects remain poorly understood. Using isolated perfused rat hea...
Autores principales: | Mancardi, Daniele, Pagliaro, Pasquale, Ridnour, Lisa A., Tocchetti, Carlo G., Miranda, Katrina, Juhaszova, Magdalena, Sollott, Steven J., Wink, David A., Paolocci, Nazareno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869498/ https://www.ncbi.nlm.nih.gov/pubmed/35204265 http://dx.doi.org/10.3390/antiox11020382 |
Ejemplares similares
-
Nitroxyl (HNO) targets phospholamban cysteines 41 and 46 to enhance cardiac function
por: Keceli, Gizem, et al.
Publicado: (2019) -
ARC regulates programmed necrosis and myocardial ischemia/reperfusion injury through the inhibition of mPTP opening
por: Xu, Tao, et al.
Publicado: (2018) -
Sirt3 targets mPTP and prevents aging in the heart
por: Sadoshima, Junichi
Publicado: (2011) -
Thiol-Activated HNO Release from a Ruthenium Antiangiogenesis
Complex and HIF-1α Inhibition for Cancer Therapy
por: Silva Sousa, Eduardo Henrique, et al.
Publicado: (2016) -
Attenuation of Skeletal Muscle and Renal Injury to the Lower Limb following Ischemia-Reperfusion Using mPTP Inhibitor NIM-811
por: Garbaisz, David, et al.
Publicado: (2014)